Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1985 1
1989 1
1990 1
1991 1
1993 2
1994 3
1995 7
1996 8
1997 4
1998 3
1999 2
2000 6
2001 6
2002 5
2003 5
2004 6
2005 3
2006 2
2007 4
2008 1
2009 3
2010 3
2011 2
2012 5
2013 10
2014 6
2015 5
2016 8
2017 5
2018 2
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
Syphilis during pregnancy: a preventable threat to maternal-fetal health.
Rac MW, Revell PA, Eppes CS. Rac MW, et al. Am J Obstet Gynecol. 2017 Apr;216(4):352-363. doi: 10.1016/j.ajog.2016.11.1052. Epub 2016 Dec 9. Am J Obstet Gynecol. 2017. PMID: 27956203 Review.
Recently, there has been an increase in the number of congenital syphilis cases in the United States. Thus, recognition and appropriate treatment of reproductive-age women must be a priority. ...Thereafter, the remaining benzathine penicillin G doses c …
Recently, there has been an increase in the number of congenital syphilis cases in the United States. Thus, recognition and ap …
Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report.
Yawn BP, John-Sowah J. Yawn BP, et al. Am Fam Physician. 2015 Dec 15;92(12):1069-76. Am Fam Physician. 2015. PMID: 26760593 Free article.
Children with sickle cell anemia should receive prophylactic penicillin from birth through at least five years of age, and all persons with sickle cell disease require vaccination to prevent invasive pneumococcal disease. ...There is strong evid …
Children with sickle cell anemia should receive prophylactic penicillin from birth through at least five years of age, …
Antibiotic Prophylaxis for Children With Sickle Cell Anemia.
Reeves SL, Tribble AC, Madden B, Freed GL, Dombkowski KJ. Reeves SL, et al. Pediatrics. 2018 Mar;141(3):e20172182. doi: 10.1542/peds.2017-2182. Epub 2018 Feb 5. Pediatrics. 2018. PMID: 29437860 Free PMC article.
BACKGROUND: Children with sickle cell anemia (SCA) are at increased risk for invasive pneumococcal disease; antibiotic prophylaxis significantly reduces this risk. ...Each additional sickle cell disease-related outpatient visit (odds ratio = 1.01, 95% …
BACKGROUND: Children with sickle cell anemia (SCA) are at increased risk for invasive pneumococcal disease; antibiotic prophyl …
Pediatric sickle cell disease: past successes and future challenges.
Meier ER, Rampersad A. Meier ER, et al. Pediatr Res. 2017 Jan;81(1-2):249-258. doi: 10.1038/pr.2016.204. Epub 2016 Oct 5. Pediatr Res. 2017. PMID: 27706129 Review.
Once a fatal disease of childhood, more than 95% of patients born today with sickle cell disease (SCD) in developed countries are expected to survive into adulthood, largely because of improvements in supportive and preventive care (newborn screening, penicillin
Once a fatal disease of childhood, more than 95% of patients born today with sickle cell disease (SCD) in developed countries …
Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
Chen CJ, Bakeera-Kitaka S, Mupere E, Kasirye P, Munube D, Idro R, Hume H, Pfeffer B, LaRussa P, Green NS. Chen CJ, et al. J Paediatr Child Health. 2019 Jul;55(7):795-801. doi: 10.1111/jpc.14291. Epub 2018 Nov 9. J Paediatr Child Health. 2019. PMID: 30411430 Free PMC article.
AIM: We aimed to assess the receipt of recommended care for young children with sickle cell disease (SCD) in a central SCD clinic in Kampala Uganda, focusing on standard vaccination and antibacterial and antimalarial prophylaxis. ...In an overlapping sample of 147 c …
AIM: We aimed to assess the receipt of recommended care for young children with sickle cell disease (SCD) in a central SCD cli …
Sickle Cell Disease.
Bender MA. Bender MA. 2003 Sep 15 [updated 2017 Aug 17]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20301551 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Sickle cell disease (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolytic anemia. ...Hb S/S (homozygous p.Glu6Val in HBB) accounts for 60%-70% of SCD in the United States. Other forms of SCD result …
CLINICAL CHARACTERISTICS: Sickle cell disease (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolyt …
A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease.
Duncan NA, Kronenberger WG, Hampton KC, Bloom EM, Rampersad AG, Roberson CP, Shapiro AD. Duncan NA, et al. Patient Prefer Adherence. 2016 Jun 8;10:983-92. doi: 10.2147/PPA.S103874. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27354768 Free PMC article.
BACKGROUND: Antibiotic prophylaxis is a mainstay in sickle cell disease management. However, adherence is estimated at only 66%. This study aimed to develop and validate a Sickle Cell Antibiotic Adherence Level Evaluation (SCAALE) to promote systematic …
BACKGROUND: Antibiotic prophylaxis is a mainstay in sickle cell disease management. However, adherence is estimated at only 66 …
How we prevent and manage infection in sickle cell disease.
Sobota A, Sabharwal V, Fonebi G, Steinberg M. Sobota A, et al. Br J Haematol. 2015 Sep;170(6):757-67. doi: 10.1111/bjh.13526. Epub 2015 May 27. Br J Haematol. 2015. PMID: 26018640 Review.
Sickle cell disease (SCD) affects approximately 100,000 people in the US, 12,500 in the UK, and millions worldwide. SCD is typified by painful vaso-occlusive episodes, haemolytic anaemia and organ damage. ...Universal newborn screening, routine use of penicillin
Sickle cell disease (SCD) affects approximately 100,000 people in the US, 12,500 in the UK, and millions worldwide. SCD is typ
Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
Bauer DE, Brendel C, Fitzhugh CD. Bauer DE, et al. Blood Cells Mol Dis. 2017 Sep;67:155-168. doi: 10.1016/j.bcmd.2017.08.014. Epub 2017 Sep 1. Blood Cells Mol Dis. 2017. PMID: 28893518 Review.
Despite sickle cell disease (SCD) first being reported >100years ago and molecularly characterized >50years ago, patients continue to experience severe morbidity and early mortality. Although there have been substantial clinical advances with immunizations, …
Despite sickle cell disease (SCD) first being reported >100years ago and molecularly characterized >50years ago, patient …
Novel insights in the management of sickle cell disease in childhood.
Iughetti L, Bigi E, Venturelli D. Iughetti L, et al. World J Clin Pediatr. 2016 Feb 8;5(1):25-34. doi: 10.5409/wjcp.v5.i1.25. eCollection 2016 Feb 8. World J Clin Pediatr. 2016. PMID: 26862499 Free PMC article. Review.
Sickle cell disease (SCD) is a life-threatening genetic disorder characterized by chronic hemolytic anemia, vascular injury and multiorgan dysfunctions. ...Hydroxyurea (Hydroxycarbamide, HU), the only medication approved as a disease-modifying agent by the United
Sickle cell disease (SCD) is a life-threatening genetic disorder characterized by chronic hemolytic anemia, vascular injury an
119 results
Jump to page
Feedback